Skip to content

Member News Update from Lab Data Solutions LLC

Date: March 14, 2026

This news piece has been submitted by Lab Data Solutions LLC

We’re Attending US Summit 2026!

Lab Data Solutions LLC is pleased to announce that we will be attending the ACDM US Summit 2026, taking place May 18–19, 2026, in Princeton, New Jersey. Hosted by Genmab, this inaugural Summit marks an important milestone for the clinical data management community—and for us, it represents our first public appearance as a company.

The ACDM US Summit brings together leading voices in Clinical Data Management and the broader clinical research ecosystem to advance discussion, collaboration, and shared learning. Designed as a forum for both scientific and practical exchange, the Summit focuses on strengthening how data management supports trust, innovation, and impact across clinical research.

Under the theme “Clinical Data Management at the Heart: Driving Trust, Innovation, and Impact,” the programme includes thought‑leadership sessions, real‑world case discussions, and meaningful networking opportunities. The event will begin with a networking evening on May 18, followed by a full day of focused sessions and discussions on May 19.

As a company dedicated to supporting high‑quality lab data and reliable data review processes, Lab Data Solutions LLC values opportunities to engage directly with peers, sponsors, CROs, and data professionals who share a commitment to data integrity and operational excellence. The Summit’s emphasis on collaboration and inclusivity—welcoming participants from across the global ACDM community—aligns closely with our own approach to clinical data work.

We look forward to learning from industry leaders, contributing to conversations shaping the future of clinical data management, and building connections within the clinical research community. If you will be attending the ACDM US Summit 2026, we would welcome the opportunity to connect and exchange perspectives.

 


 

Explore More News

ACDM DMEG shares update on CDISC Community Review

Thank you to the ACDM Regulatory Considerations DMEG for sharing the following important . . .

Read More

Get to know: Rachel Lesser

We caught up with Rachel Lesser, member of the ACDM Hot Topic Committee, to learn more . . .

Read More

Regulatory Considerations DMEG Shares Update on ICH E6(R3) Training Modules Available

The ICH Working Groups and The ICH Training Associates have released two new training . . .

Read More

Recent update from the regulatory landscape in clinical data management

On 22 September, MHRA published a new set of inspection dossier documents specifically for . . .

Read More

Regulatory Considerations DMEG Update – August 2026

Please read the following update from the Regulatory Considerations DMEG:  July and . . .

Read More

Get to know ACDM Board Member: Santosh Karthikeyan Viswanathan

We caught up with one of ACDM’s new Board Members, Santosh Karthikeyan Viswanathan, to . . .

Read More

Guidance on Decentralized Clinical Trials to be Reviewed by the ACDM RC DMEG

Health Canada (HC) continues to publish new guidelines to support their modernization of . . .

Read More

Regulatory Considerations DMEG to Review Health Canada’s Draft Guidance

Thank you to the Regulatory Considerations DMEG for sharing this update. Health Canada . . .

Read More

Recent update from the regulatory landscape in clinical data management

Thank you to the Regulatory Considerations DMEG for sharing this update. On July 15 the . . .

Read More

Regulatory Considerations DMEG Update – June 2026

Please read the following update from the Regulatory Considerations DMEG:  Regulators have . . .

Read More

FDA Announces New Initiative for Real-Time Clinical Trials

The U.S. Food and Drug Administration (FDA) has announced a new initiative to support the . . .

Read More

Get to know ACDM Board Member Jennifer Duff

We caught up with one of ACDM’s new Board Members, Jennifer Duff, to learn more about her. . . .

Read More